Evidence-Based Recommendations for Monitoring Safety of Second Generation Antipsychotics in Children and Youth

摘要

Background:The use of antipsychotics, especially second generation antipsychotics (SGAs), for children with mental health disorders in Canada has increased dramatically over the past five years. These medications have the potential to cause major metabolic and neurological complications with chronic use.